- Home
- CARM vs COSM Comparison
CARM vs COSM Comparison
Compare CARM & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARM
- COSM
- Stock Information
- Founded
- CARM 2016
- COSM 2009
- Country
- CARM United States
- COSM United States
- Employees
- CARM N/A
- COSM N/A
- Industry
- CARM Biotechnology: Pharmaceutical Preparations
- COSM Other Pharmaceuticals
- Sector
- CARM Health Care
- COSM Health Care
- Exchange
- CARM Nasdaq
- COSM Nasdaq
- Market Cap
- CARM 12.2M
- COSM 12.3M
- IPO Year
- CARM N/A
- COSM 2013
- Fundamental
- Price
- CARM $0.24
- COSM $0.84
- Analyst Decision
- CARM Hold
- COSM
- Analyst Count
- CARM 5
- COSM 0
- Target Price
- CARM $0.90
- COSM N/A
- AVG Volume (30 Days)
- CARM 447.9K
- COSM 1.4M
- Earning Date
- CARM 08-07-2025
- COSM 08-18-2025
- Dividend Yield
- CARM N/A
- COSM N/A
- EPS Growth
- CARM N/A
- COSM N/A
- EPS
- CARM N/A
- COSM N/A
- Revenue
- CARM $10,767,000.00
- COSM $55,093,442.00
- Revenue This Year
- CARM N/A
- COSM $28.14
- Revenue Next Year
- CARM N/A
- COSM N/A
- P/E Ratio
- CARM N/A
- COSM N/A
- Revenue Growth
- CARM N/A
- COSM N/A
- 52 Week Low
- CARM $0.14
- COSM $0.28
- 52 Week High
- CARM $1.27
- COSM $1.42
- Technical
- Relative Strength Index (RSI)
- CARM 31.94
- COSM 55.40
- Support Level
- CARM $0.21
- COSM $0.74
- Resistance Level
- CARM $0.31
- COSM $0.93
- Average True Range (ATR)
- CARM 0.03
- COSM 0.16
- MACD
- CARM -0.00
- COSM -0.02
- Stochastic Oscillator
- CARM 23.64
- COSM 20.92
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.